These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3162745)

  • 1. Mechanism of target cytolysis by peptide defensins. Target cell metabolic activities, possibly involving endocytosis, are crucial for expression of cytotoxicity.
    Lichtenstein AK; Ganz T; Nguyen TM; Selsted ME; Lehrer RI
    J Immunol; 1988 Apr; 140(8):2686-94. PubMed ID: 3162745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of mammalian cell lysis mediated by peptide defensins. Evidence for an initial alteration of the plasma membrane.
    Lichtenstein A
    J Clin Invest; 1991 Jul; 88(1):93-100. PubMed ID: 2056135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The autocrine-paracrine modulation of natural killer activity in man by peptides of the corticostatin-defensin family].
    Masera RG; Gatti G; Bateman A; Solomon S; Sartori ML; Staurenghi A; Lazzero A; Griot G; Angeli A
    Ann Ital Med Int; 1993; 8(2):80-5. PubMed ID: 8353023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human interleukin-2-activated adherent natural killer cells recognize a conserved antigen found on tumor cells and protozoan parasites.
    Weisman Z; Evans DL; Jaso-Friedmann L
    Nat Immun; 1996-1997; 15(6):269-84. PubMed ID: 9523279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target-effector cell interaction in the natural killer cell system. V. Energy requirements, membrane integrity, and the possible involvement of lysosomal enzymes.
    Roder JC; Argov S; Klein M; Petersson C; Kiessling R; Andersson K; Hansson M
    Immunology; 1980 May; 40(1):107-16. PubMed ID: 6968289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of human cell-mediated cytotoxicity. III. Dependence of natural killing on microtubule and microfilament integrity.
    Katz P; Zaytoun AM; Lee JH
    J Immunol; 1982 Dec; 129(6):2816-25. PubMed ID: 6890568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between fresh human blood monocytes and tumor targets at the single cell level: binding and morphological characteristics.
    Muse KE; Koren HS
    J Reticuloendothel Soc; 1982 Nov; 32(5):323-37. PubMed ID: 6962303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced alterations of tumor necrosis factor-mediated cytotoxicity: discrimination of early versus late stage action.
    Kull FC; Besterman JM
    J Cell Biochem; 1990 Jan; 42(1):1-12. PubMed ID: 2298825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct functions of surface receptors in the induction of neutrophil-mediated cytotoxicity.
    Cordier G; Samarut C; Revillard JP
    Ann Immunol (Paris); 1981; 132D(1):3-14. PubMed ID: 7347555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
    Neville ME; Hiserodt JC
    J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mechanism for neutrophil-mediated lysis of human neuroblastoma cells.
    Barker E; Reisfeld RA
    Cancer Res; 1993 Jan; 53(2):362-7. PubMed ID: 8417829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human monocyte-mediated tumor cytotoxicity. I. Demonstration of an oxygen-dependent myeloperoxidase-independent mechanism.
    Mavier P; Edgington TS
    J Immunol; 1984 Apr; 132(4):1980-6. PubMed ID: 6321594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human monocyte-mediated lysis of antibody-coated tumor cells: the role of the cytoskeleton in monocytes.
    Espevik T
    J Immunol; 1985 Mar; 134(3):2017-25. PubMed ID: 3881531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human neutrophilic defensin modulates the functional activity of the monocytes].
    Tkachenko SB; Fesenko OV; Korneva EA; Ashmarin IP; Kubatiev AA
    Biull Eksp Biol Med; 1993 Nov; 116(11):474-6. PubMed ID: 8312532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of antimicrobial peptides of neutrophils on tumor and normal cells in culture].
    Shamova OV; Sakuta GA; Orlov DS; Zenin VV; Shteĭn GI; Kolodkin NI; Afonina IV; Kokriakov VN
    Tsitologiia; 2007; 49(12):1000-10. PubMed ID: 18318218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil alpha-defensin human neutrophil peptide modulates cytokine production in human monocytes and adhesion molecule expression in endothelial cells.
    Chaly YV; Paleolog EM; Kolesnikova TS; Tikhonov II; Petratchenko EV; Voitenok NN
    Eur Cytokine Netw; 2000 Jun; 11(2):257-66. PubMed ID: 10903805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis.
    Panyutich AV; Panyutich EA; Krapivin VA; Baturevich EA; Ganz T
    J Lab Clin Med; 1993 Aug; 122(2):202-7. PubMed ID: 8340706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines.
    Johnstone SA; Gelmon K; Mayer LD; Hancock RE; Bally MB
    Anticancer Drug Des; 2000 Apr; 15(2):151-60. PubMed ID: 10901303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of altered membrane fluidity on NK cell-mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition events in the cytolytic pathway of NK cells.
    Roozemond RC; Bonavida B
    J Immunol; 1985 Apr; 134(4):2209-14. PubMed ID: 3855929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.